Nuvectis Pharma Inc.
5.48
-0.16 (-2.84%)
At close: Jan 15, 2025, 2:54 PM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20
Revenue n/a 149.00K n/a n/a
Cost of Revenue 22.90M 19.23M 12.89M n/a
Gross Profit -22.90M -19.09M -12.89M n/a
Operating Income -22.90M -19.23M -12.89M -10.00K
Interest Income 637.00K 149.00K 4.00K n/a
Pretax Income -22.26M -19.09M -12.89M -10.00K
Net Income -22.26M -18.79M -12.89M -10.00K
Selling & General & Admin 7.52M 6.01M 3.35M 10.00K
Research & Development 15.38M 13.23M 9.54M n/a
Other Expenses n/a n/a n/a n/a
Operating Expenses 22.90M 19.23M 12.89M 10.00K
Interest Expense n/a 149.00K n/a n/a
Selling & Marketing Expenses 14.00K n/a n/a 9.98K
Cost & Expenses 22.90M 19.23M 12.89M 10.00K
Income Tax n/a -298.00K -4.00K -24
Shares Outstanding (Basic) 15.56M 12.66M 12.72M 12.72M
Shares Outstanding (Diluted) 15.56M 12.66M 12.72M 12.72M
EPS (Basic) -1.43 -1.48 -1.01 -0.00
EPS (Diluted) -1.43 -1.48 -1.01 -0.00
EBITDA -22.90M -19.23M -12.89M n/a
Depreciation & Amortization -1.00M -1.20M -7.10M 24.00K